Examination of the Reasons for Change in Treatment in Patients Infected with Human Immunodeficiency Virus

Introduction: Highly active antiretroviral therapy (HAART) has significantly reduced morbidity and mortality in patients infected with Human immunodeficiency virus (HIV). Despite this success, the sustainability of the initial treatment regimen has become difficult as patients continue the treatment...

Full description

Bibliographic Details
Main Authors: Mehmet ÇABALAK, Tayibe BAL, Eda Selin POLAT, Sabahattin OCAK, Yusuf ÖNLEN
Format: Article
Language:Turkish
Published: Galenos Yayinevi 2023-05-01
Series:Mediterranean Journal of Infection, Microbes and Antimicrobials
Subjects:
Online Access:https://mjima.org/text.php?&id=362
_version_ 1797826802130878464
author Mehmet ÇABALAK
Tayibe BAL
Eda Selin POLAT
Sabahattin OCAK
Yusuf ÖNLEN
author_facet Mehmet ÇABALAK
Tayibe BAL
Eda Selin POLAT
Sabahattin OCAK
Yusuf ÖNLEN
author_sort Mehmet ÇABALAK
collection DOAJ
description Introduction: Highly active antiretroviral therapy (HAART) has significantly reduced morbidity and mortality in patients infected with Human immunodeficiency virus (HIV). Despite this success, the sustainability of the initial treatment regimen has become difficult as patients continue the treatment for life. Highly active antiretroviral therapy regimen change may often be necessary due to intolerance/toxicity, pregnancy, comorbidities, difficulty in patient compliance and failure to achieve virological suppression. In this study, it was aimed to examine the reasons for HAART change in patients followed up for HIV/AIDS in Hatay Mustafa Kemal University, Tayfur Ata Sökmen Faculty of Medicine Hospital. Materials and Methods: In this retrospective, cross-sectional, single-center study, 151 patients followed up at Hatay Mustafa Kemal University, Tayfur Ata Sökmen Medical Faculty Hospital for HIV between January 2018 and December 2020 were included in the study. Results: One hundred-seventeen (77.5%) of the cases were male and 34 (22.5%) were female. The mean age was 39.08±14.2 years (20-83). Treatment changes were made in 35 (23.2%) of the cases. The most common reason for treatment change was intolerance/toxicity (19) in 12.6% of cases. Other reasons for change; pregnancy was six (4%), treatment non-compliance was four (2.6%), patient request was three (2%), and physician decision was three (2%). No drug changes were detected in the cases due to virological failure. Conclusion: There is generally little data available in Turkey on the reasons for regime change in HIV patients using HAART. Therefore, the data we will obtain in this study can help draw a long-term plan for HAART drug management.
first_indexed 2024-04-09T12:38:03Z
format Article
id doaj.art-d9e8ecc39d854cd39c88716bb629f8ce
institution Directory Open Access Journal
issn 2147-673X
language Turkish
last_indexed 2024-04-09T12:38:03Z
publishDate 2023-05-01
publisher Galenos Yayinevi
record_format Article
series Mediterranean Journal of Infection, Microbes and Antimicrobials
spelling doaj.art-d9e8ecc39d854cd39c88716bb629f8ce2023-05-15T08:44:11ZturGalenos YayineviMediterranean Journal of Infection, Microbes and Antimicrobials2147-673X2023-05-0112110.4274/mjima.galenos.2023.2022.2Examination of the Reasons for Change in Treatment in Patients Infected with Human Immunodeficiency VirusMehmet ÇABALAK0https://orcid.org/0000-0003-1148-2247Tayibe BAL1https://orcid.org/0000-0002-5315-122XEda Selin POLAT2https://orcid.org/0000-0002-6113-6281Sabahattin OCAK3https://orcid.org/0000-0002-8095-4378Yusuf ÖNLEN4https://orcid.org/0000-0002-8163-1368Hatay Mustafa Kemal University, Tayfur Ata Sökmen Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Hatay, TurkeyHatay Mustafa Kemal University, Tayfur Ata Sökmen Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Hatay, TurkeyHatay Mustafa Kemal University, Tayfur Ata Sökmen Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Hatay, TurkeyHatay Mustafa Kemal University, Tayfur Ata Sökmen Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Hatay, TurkeyHatay Mustafa Kemal University, Tayfur Ata Sökmen Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Hatay, TurkeyIntroduction: Highly active antiretroviral therapy (HAART) has significantly reduced morbidity and mortality in patients infected with Human immunodeficiency virus (HIV). Despite this success, the sustainability of the initial treatment regimen has become difficult as patients continue the treatment for life. Highly active antiretroviral therapy regimen change may often be necessary due to intolerance/toxicity, pregnancy, comorbidities, difficulty in patient compliance and failure to achieve virological suppression. In this study, it was aimed to examine the reasons for HAART change in patients followed up for HIV/AIDS in Hatay Mustafa Kemal University, Tayfur Ata Sökmen Faculty of Medicine Hospital. Materials and Methods: In this retrospective, cross-sectional, single-center study, 151 patients followed up at Hatay Mustafa Kemal University, Tayfur Ata Sökmen Medical Faculty Hospital for HIV between January 2018 and December 2020 were included in the study. Results: One hundred-seventeen (77.5%) of the cases were male and 34 (22.5%) were female. The mean age was 39.08±14.2 years (20-83). Treatment changes were made in 35 (23.2%) of the cases. The most common reason for treatment change was intolerance/toxicity (19) in 12.6% of cases. Other reasons for change; pregnancy was six (4%), treatment non-compliance was four (2.6%), patient request was three (2%), and physician decision was three (2%). No drug changes were detected in the cases due to virological failure. Conclusion: There is generally little data available in Turkey on the reasons for regime change in HIV patients using HAART. Therefore, the data we will obtain in this study can help draw a long-term plan for HAART drug management.https://mjima.org/text.php?&id=362hivhighly active antiretroviral therapychange in therapy
spellingShingle Mehmet ÇABALAK
Tayibe BAL
Eda Selin POLAT
Sabahattin OCAK
Yusuf ÖNLEN
Examination of the Reasons for Change in Treatment in Patients Infected with Human Immunodeficiency Virus
Mediterranean Journal of Infection, Microbes and Antimicrobials
hiv
highly active antiretroviral therapy
change in therapy
title Examination of the Reasons for Change in Treatment in Patients Infected with Human Immunodeficiency Virus
title_full Examination of the Reasons for Change in Treatment in Patients Infected with Human Immunodeficiency Virus
title_fullStr Examination of the Reasons for Change in Treatment in Patients Infected with Human Immunodeficiency Virus
title_full_unstemmed Examination of the Reasons for Change in Treatment in Patients Infected with Human Immunodeficiency Virus
title_short Examination of the Reasons for Change in Treatment in Patients Infected with Human Immunodeficiency Virus
title_sort examination of the reasons for change in treatment in patients infected with human immunodeficiency virus
topic hiv
highly active antiretroviral therapy
change in therapy
url https://mjima.org/text.php?&id=362
work_keys_str_mv AT mehmetcabalak examinationofthereasonsforchangeintreatmentinpatientsinfectedwithhumanimmunodeficiencyvirus
AT tayibebal examinationofthereasonsforchangeintreatmentinpatientsinfectedwithhumanimmunodeficiencyvirus
AT edaselinpolat examinationofthereasonsforchangeintreatmentinpatientsinfectedwithhumanimmunodeficiencyvirus
AT sabahattinocak examinationofthereasonsforchangeintreatmentinpatientsinfectedwithhumanimmunodeficiencyvirus
AT yusufonlen examinationofthereasonsforchangeintreatmentinpatientsinfectedwithhumanimmunodeficiencyvirus